齐禾生科联合创始人、CEO兼CTO赵天萌博士表示
Company Detail
齐禾生物
齐禾生物提供自主可控的新型基因编辑技术，探索其在生物育种等领域的应用。
AIStage待补Beijing, China
Fit Score
7.4
1 signals
资料质量
75%
缺 产品 / 商业化
创始团队
2
LinkedIn 1
商业化
0
channels / payments
画像状态
Quality
75% · Ready
最新信号
齐禾生科完成超亿元A+轮融资，加速基因编辑技术产业落地与全球商业化进程
2026-05-06 · IPO早知道
Funding
2026-05-06 · 北京齐禾生物科技有限公司（下称齐禾生科）宣布完成超亿元人民币A+轮融资
产品与定位
当前缺少明确证据
创始团队与公开主页
高彩霞 · Co-founder
founder
92% confidence公开触达入口
当前缺少明确证据
商业化 / 支付信号
当前缺少明确证据
结构化事实
https://www.qi-biodesign.com/
agent_fill:company_website
93% confidence{"linkedin_url": "", "name": "高彩霞", "title": "Co-founder"}
agent_fill:founders
92% confidence{"linkedin_url": "https://www.linkedin.com/in/kevinzhao93/", "name": "Kevin Zhao", "title": "Co-founder and CTO"}
agent_fill:founders
92% confidence[{"confidence": 0.92, "evidence_urls": ["https://www.forbeschina.com/investment/60083", "https://gs.caas.cn/zsgz/zpxx/6cac2f6fc59349ef93677f4bcdea46de.htm"], "linkedin_url": "", "name": "高彩霞", "title": "Co-founder"}, {"confidence": 0.92, "evidence_urls": ["https://www.forbeschina.com/investment/60083", "https://bydrug.pharmcube.com/news/detail/3508e67054ff1d8829de9adc5b626bf5"], "linkedin_url": "https://www.linkedin.com/in/kevinzhao93/", "name": "Kevin Zhao", "title": "Co-founder and CTO"}]
agent_fill:founders
92% confidenceitem_lead_extraction
funding
92% confidenceitem_lead_extraction
funding
92% confidenceitem_lead_extraction
funding
92% confidence齐禾生物提供自主可控的新型基因编辑技术，探索其在生物育种等领域的应用。
agent_fill:company_summary
91% confidenceChina
agent_fill:hq_country
90% confidenceBeijing
agent_fill:hq_city
88% confidence来源证据
近期信号